| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604977 | International Journal of Cardiology | 2017 | 7 Pages |
Abstract
In the present experimental study, administration of ivabradine reduced inducibility of AF and therefore may represent a supplemental therapeutic option in AF. Of note, its antiarrhythmic efficacy was comparable to the established agent flecainide.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gerrit Frommeyer, Magdalena Sterneberg, Dirk G. Dechering, Christian Ellermann, Nils Bögeholz, Simon Kochhäuser, Christian Pott, Michael Fehr, Lars Eckardt,